CRISPR Therapeutics AG Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.25M5.16M41.00M3.12M289.59M0.72M914.96M1.20M371.21M37.31M
Gross Profit 0.25M5.16M41.00M3.12M289.59M0.72M914.96M1.20M371.21M37.31M
Operating items
Research & Development 1.51M12.57M42.24M69.80M113.77M179.36M221.38M340.57M461.64M387.33M320.65M
Selling, General & Administrative 5.11M13.40M31.06M35.84M48.29M63.49M85.75M99.69M102.46M76.16M72.98M
Other Operating Expenses 48.02M101.18M110.25M130.25M110.25M
Operating Expenses 6.63M25.98M73.29M105.64M162.07M242.85M355.15M541.43M674.36M593.74M503.88M
Operating Income -6.63M-25.73M-68.13M-64.65M-158.94M46.74M-354.44M373.53M-673.16M-222.54M-466.57M
EBIT -6.63M-25.73M-68.13M-64.65M-158.94M46.74M-354.44M373.53M-673.16M-222.54M-466.57M
Non-operating items
Interest & Investment Income -0.11M-8.05M
Other Non Operating Income -0.24M0.02M78.51M-0.20M-1.21M26.03M6.38M6.00M22.66M71.82M103.90M
Non Operating Income -0.24M-0.09M78.51M-1.96M-5.49M26.03M6.38M6.00M22.66M71.82M103.90M
Net income details
EBT -6.86M-25.82M-22.72M-66.61M-164.43M67.31M-355.69M379.53M-651.82M-181.08M-403.90M
Tax Provisions -0.06M0.06M0.62M1.75M0.55M0.48M0.81M1.87M0.69M3.31M4.07M
Profit After Tax -7.01M-25.83M-23.20M-68.36M-164.98M66.86M-348.87M377.66M-650.17M-153.61M-366.25M
Equity Income -36.53M-1.76M-4.28M-5.47M
Income from Non-Controlling Interests -0.54M-0.33M-0.03M36.20M52.50M
Income from Continuing Operations -6.80M-25.88M-23.34M-68.36M-164.98M66.82M-356.50M377.66M-652.51M-184.39M-407.97M
Consolidated Net Income -6.80M-25.88M-23.34M-68.36M-164.98M66.82M-356.50M377.66M-652.51M-184.39M-407.97M
Income towards Parent Company -6.80M-25.88M-23.34M-68.36M-164.98M66.82M-356.50M377.66M-652.51M-184.39M-407.97M
Net Income towards Common Stockholders -6.80M-25.88M-23.34M-68.36M-164.98M66.86M-356.50M377.66M-652.51M-184.39M-407.97M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 39.81M41.02M52.28M60.85M70.65M76.53M78.29M79.43M85.35M
Shares Outstanding (Diluted Average) 77.75M79.22M84.36M
EBITDA -6.80M-25.83M-23.22M-68.32M-165.00M66.87M-348.95M372.68M-660.75M-136.05M-366.32M
Tax Rate 0.92%0.72%0.49%